LobbyingApoe Alzheimers Alliance lobbying by quarter
Apoe Alzheimers Alliance's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q2 2025; the issues it reports most are Health Issues and Pharmacy.
Apoe Alzheimers Alliance
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $20K | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$20K · 1 reports
- Health issues$0 · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)4 reports
- Health & Human Services, Dept of (HHS)4 reports
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Rubicon Advisors | $20K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Rubicon Advisors | Under $5,000 |
| 04/23for Q1 | Rubicon Advisors | Under $5,000 |
| 01/18for Q4 2025 | Rubicon Advisors | Under $5,000 |
| 25/10/23for Q3 2025 | Rubicon Advisors | Under $5,000 |
| 25/07/19for Q2 2025 | Rubicon Advisors | $20K |
| 25/05/20for Q1 2025 | Rubicon Advisors | Under $5,000 |